Clinical Dilemmas in Primary Liver Cancer

Overview

Clinical Dilemmas in Liver Cancer follows the successful format of the other books in the Clinical Dilemmas series, with each chapter focused on a specific dilemma, or issue facing doctors in their day-to-day job, and providing them with practical clinical information and help to better assessment and treat their patients – in this case patients suffering from liver cancer, the third commonest cancer in terms of mortality worldwide.

Chapters feature up-to-date information on the...

See more details below
Paperback
$85.56
BN.com price
(Save 4%)$89.95 List Price
Other sellers (Paperback)
  • All (9) from $55.21   
  • New (8) from $55.21   
  • Used (1) from $85.55   
Clinical Dilemmas in Primary Liver Cancer

Available on NOOK devices and apps  
  • NOOK Devices
  • NOOK HD/HD+ Tablet
  • NOOK
  • NOOK Color
  • NOOK Tablet
  • Tablet/Phone
  • NOOK for Windows 8 Tablet
  • NOOK for iOS
  • NOOK for Android
  • NOOK Kids for iPad
  • PC/Mac
  • NOOK for Windows 8
  • NOOK for PC
  • NOOK for Mac
  • NOOK Study
  • NOOK for Web

Want a NOOK? Explore Now

NOOK Book (eBook)
$51.49
BN.com price
(Save 42%)$89.95 List Price

Overview

Clinical Dilemmas in Liver Cancer follows the successful format of the other books in the Clinical Dilemmas series, with each chapter focused on a specific dilemma, or issue facing doctors in their day-to-day job, and providing them with practical clinical information and help to better assessment and treat their patients – in this case patients suffering from liver cancer, the third commonest cancer in terms of mortality worldwide.

Chapters feature up-to-date information on the basic mechanisms, epidemiological risk factors, screening and surveillance strategies, diagnosis and treatment. It is an extremely practical and clinically-orientated book, and as most patients around the world present with advanced disease, a main focus is on the most recent advances allowing early diagnosis and use of locoregional and systemic therapy, surgery, transplantation and combination therapies. Each chapter is authored by an international expert in the relevant area.

 

Read More Show Less

Editorial Reviews

From the Publisher
“This book is a useful introduction to HCC.” (Gastroenterology, 1 August 2012)
Read More Show Less

Product Details

  • ISBN-13: 9780470657973
  • Publisher: Wiley
  • Publication date: 2/21/2012
  • Series: Clinical Dilemmas (UK) Series
  • Edition number: 1
  • Pages: 230
  • Product dimensions: 7.40 (w) x 9.70 (h) x 0.60 (d)

Read an Excerpt

Click to read or download

Read More Show Less

Table of Contents

List of Contributors.

Preface.

Part 1: Learning from a Worldwide Perspective.

1 Are patterns and prevalence changing? (Hashem B. El-Serag).

2 Why is the tumour different in Africa? (Nimzing G. Ladep).

3 Control by vaccination: Asian and Taiwan experience (Jia-Horng Kao).

4 The view from the UK (Shahid A. Khan, Mireille B. Toledano, Abigail Zabron, Mehtan Ahmed, and Simon D. Taylor-Robinson).

5 The view from the United States (Hitoshi Maruyama and Arun J. Sanyal).

6 New challenges of NAFLD and HIV epidemics (Quentin M. Anstee and Janice Main).

Part 2: Influence of Tumour Characteristics.

7 Controversies in Pathology (Tania Roskams).

8 Not to forget the unusual tumour (Bernard C. Portmann).

9 What can be learned from molecular diagnostic techniques and genetic signatures? (Tariq Moatter and Saeed Hamid).

Part 3: Complexities of Patient Assessment and Scoring Systems.

10 Looking after the liver as well as the tumour (Roger Williams).

11 Comparative performances of staging systems for hepatocellular cancer: Early HCC considerations (Peter D. Peng, Timothy M. Pawlik).

12 Rival scoring systems: Do they offer more? (Angelo Sangiovanni and Massimo Colombo).

13 Is it possible to detect early lesions effectively? (Ryota Masuzaki and Masao Omata).

14 What is the value of country based surveillance programmes? (Peter Ott).

Part 4: Choice of Radiological Diagnostic Technique.

15 Computed tomography or magnetic resonance imaging for the diagnosis of hepatocellular carcinoma (Wladyslaw Gedroyc).

16 Is Microbubble ultrasound useful? (Adrian Lim).

17 Value of PET scanning (Tara Barwick, Imene Zerizer, and Adil Al-Nahhas).

Part 5: Can Treatment be Tailored to the Patient?

18 Who could benefit from chemoembolisation? (Gisèle N'Kontchou, Olivier Seror, and Michel Beaugrand).

19 Are drug eluting beads (DEB) worth using? (C. N. Hacking and Pradesh Kumar).

20 What's the future of image-guided radiofrequency ablation for hepatocellular carcinoma? (Riccardo Lencioni).

21 Alternative ablation techniques for hepatocellular carcinoma (John Karani).

22 Justification for Sorafenib and chemotherapy (Philip J. Johnson).

23 When to consider surgery? (Emmanuel Melloul, Mickaël Lesurtel, and Pierre-Alain Clavien).

24 Transplant considerations (Myron Schwartz).

Part 6: What Does the Future Hold?

25 Dipstick markers for diagnosis: Feasible or not? (Mohamed I. F. Shariff and Simon D. Taylor-Robinson).

26 Targeted gene therapy for hepatocellular carcinoma (HCC): A reality? (Christopher Binny, Marco Della Peruta, and Amit C. Nathwani).

27 Is immune modulation a possibility? (Tim F. Greten and Firouzeh Korangy).

28 Systemic therapy for hepatocellular carcinoma: Future directions (Daniel H. Palmer, Matthew Cramp).

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)